Manifesto for a European Anxiety Disorders Research Network

Baldwin, David S.; Allgulander, Christer; Altamura, Alfredo Carlo; Angst, Jules; Bandelow, Borwin; den Boer, Johan; Boyer, Patrice; Davies, Simon; dell'Osso, Bernardo; Eriksson, Elias; Fineberg, Naomi; Fredrikson, Mats; Herran, Andres; Maron, Eduard; Metspalu, Andres; Nutt, David; van der Wee, Nic; Vázquez-Barquero, Jose Luis; Zohar, Joseph

doi:10.1016/j.euroneuro.2010.02.015

« Previous Next »European Neuropsychopharmacology
Volume 20, Issue 6 , Pages 426-432, June 2010

Manifesto for a European Anxiety Disorders Research Network

David S. Baldwin
- Clinical Neuroscience Division, University of Southampton School of Medicine, Southampton, UK
- Corresponding author. Tel.: +44 2380 825533; fax +2380 234243.
Christer Allgulander
- Karolinska Institutet, Stockholm, Sweden
Alfredo Carlo Altamura
- Department of Psychiatry, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy
Jules Angst
- Zurich University Psychiatric Hospital, Zurich, Switzerland
Borwin Bandelow
- Department of Psychiatry and Psychotherapy, University of Goettingen, Goettingen, Germany
Johan den Boer
- University Medical Centre Groningen, Department of Psychiatry, Groningen, The Netherlands
Patrice Boyer
- University Paris 7, Paris, France
Simon Davies
- Academic Unit of Psychiatry, University of Bristol, Bristol, UK
Bernardo dell'Osso
- Department of Psychiatry, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy
Elias Eriksson
- Department of Pharmacology, Gothenberg University, Gothenberg, Sweden
Naomi Fineberg
- Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, UK
Mats Fredrikson
- Department of Psychology, Uppsala University, Uppsala, Sweden
Andres Herran
- Psychiatric Research Unit of Cantabria, Department of Psychiatry, CIBERSAM, University of Cantabria, Santander, Spain
Eduard Maron
- Estonian Genome Center and IMCB, University of Tartu, Estonia
- Department of Neuropsychopharmacology and Molecular Imaging, Imperial College of Medicine, London UK
Andres Metspalu
- Estonian Genome Center and IMCB, University of Tartu, Estonia
David Nutt
- Department of Neuropsychopharmacology and Molecular Imaging, Imperial College of Medicine, London UK
Nic van der Wee
- Department of Psychiatry, Leiden University Medical Center and Leiden Institute for Brain and Cognition, Leiden, The Netherlands
Jose Luis Vázquez-Barquero
- Psychiatric Research Unit of Cantabria, Department of Psychiatry, CIBERSAM, University of Cantabria, Santander, Spain
Joseph Zohar
- Chaim Sheba Medical Centre, Tel Hashomer, Israel

Received 21 December 2009; received in revised form 9 February 2010; accepted 14 February 2010. published online 31 March 2010.

Abstract

Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.

Keywords: Anxiety disorders, Research network, Treatment, Outcomes